At the end of 2024,
the City Court issued a ruling concerning the classification of a
medicinal product as the first similar product or generic. The court reviewed
several claims raised against decisions of the Ministry of Health (MoH) and the
State Institute for Drug Control (SÚKL).
A similar product
is, in simplified terms, a medicinal product with the same active substance(s)
and an identical...
Are you interested in reading regular commentaries on decisions by Pharmeca a.s.? Feel free to contact us.
At Pharmeca, we help you navigate the complex landscape of pharmaceutical and medical device information. We also offer flexible services that can be tailored to your needs at any time.
Our market position and experience allow us to support you whenever you need expert guidance.
Our knowledge, your opportunity.
